Sachin Jain
Stock Analyst at Bank of America Securities
(3.12)
# 2,548
Out of 5,073 analysts
238
Total ratings
53.2%
Success rate
2.5%
Average return
Main Sectors:
Stocks Rated by Sachin Jain
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: NOVN Novartis AG | Reiterated: Buy | CHF 150.00 | CHF 126.88 | +18.22% | 32 | Oct 12, 2026 | |
| NVS Novartis AG | Reiterated: Buy | $185 | $153.93 | +20.18% | 8 | Oct 12, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €92.00 | €73.57 | +25.05% | 25 | Oct 8, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 16,500p | 12,614p | +30.81% | 89 | Oct 5, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 2,350p | 1,868p | +25.80% | 16 | Sep 4, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Reiterated: Buy | €30.00 → €35.00 | €44.63 | -21.58% | 9 | Dec 2, 2025 | |
| BME: GRF Grifols, S.A. | Reiterated: Buy | €10.60 | €10.09 | +5.11% | 1 | Nov 25, 2025 | |
| GSK GSK plc | Reiterated: Sell | $48 → $23 | $50.02 | -54.91% | 4 | Oct 29, 2025 | |
| NVO Novo Nordisk | Reiterated: Hold | $137 → $56 | $39.06 | n/a | 37 | Oct 9, 2025 | |
| SWX: ROP Roche Holding AG | Upgraded: Buy | CHF 275.00 → CHF 340.00 | CHF 392.00 | n/a | 6 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €110.00 → €205.00 | €142.25 | n/a | 3 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $49 | $39.57 | n/a | 4 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 | $19.10 | n/a | 1 | Feb 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $195 | $245.81 | n/a | 1 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $29.85 | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $240.26 | n/a | 1 | May 2, 2016 |
Novartis AG
Oct 12, 2026
Reiterated: Buy
Price Target: CHF 150.00
Current: CHF 126.88
Upside: +18.22%
Novartis AG
Oct 12, 2026
Reiterated: Buy
Price Target: $185
Current: $153.93
Upside: +20.18%
Sanofi
Oct 8, 2026
Reiterated: Hold
Price Target: €92.00
Current: €73.57
Upside: +25.05%
AstraZeneca PLC
Oct 5, 2026
Reiterated: Buy
Price Target: 16,500p
Current: 12,614p
Upside: +30.81%
GSK plc
Sep 4, 2026
Reiterated: Hold
Price Target: 2,350p
Current: 1,868p
Upside: +25.80%
Bayer Aktiengesellschaft
Dec 2, 2025
Reiterated: Buy
Price Target: €30.00 → €35.00
Current: €44.63
Upside: -21.58%
Grifols, S.A.
Nov 25, 2025
Reiterated: Buy
Price Target: €10.60
Current: €10.09
Upside: +5.11%
GSK plc
Oct 29, 2025
Reiterated: Sell
Price Target: $48 → $23
Current: $50.02
Upside: -54.91%
Novo Nordisk
Oct 9, 2025
Reiterated: Hold
Price Target: $137 → $56
Current: $39.06
Upside: n/a
Roche Holding AG
Sep 13, 2024
Upgraded: Buy
Price Target: CHF 275.00 → CHF 340.00
Current: CHF 392.00
Upside: n/a
Jun 12, 2023
Reiterated: Buy
Price Target: €110.00 → €205.00
Current: €142.25
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $48 → $49
Current: $39.57
Upside: n/a
Feb 2, 2023
Reiterated: Hold
Price Target: $24
Current: $19.10
Upside: n/a
Jan 17, 2023
Reiterated: Hold
Price Target: $195
Current: $245.81
Upside: n/a
Nov 1, 2022
Reiterated: Buy
Price Target: $60
Current: $29.85
Upside: n/a
May 2, 2016
Reiterated: Buy
Price Target: n/a
Current: $240.26
Upside: n/a